Dilaware Khan
Papers
1
Total Citations
16
H-Index
1
About
Dilaware Khan is a pioneering researcher at the intersection of neuro-oncology, stem cell biology, and automated drug discovery. His work centers on glioblastoma, the most aggressive form of brain cancer, where he investigates how the tumor’s stem cell hierarchy and neurotransmitter microenvironment can be therapeutically exploited. In his landmark 2020 study, Khan and his team programmed a robotic workstation to autonomously screen for drugs that target glioblastoma stem cells. This innovative approach led to the identification of a Parkinson’s disease therapeutic as a promising repurposing candidate, directly addressing a critical clinical need for more effective, targeted treatments. With 16 citations, this paper exemplifies his impact in merging high-throughput robotics with precision oncology. Khan’s contributions are notable for bridging engineering and biology, demonstrating how automated systems can uncover unexpected drug vulnerabilities in lethal cancers. His work not only advances our understanding of glioblastoma’s cellular hierarchy but also offers a scalable, reproducible framework for future drug discovery, making him a key figure in the push toward personalized, mechanism-driven therapies for brain tumors.
Research Focus
Key Achievements
Top Papers
- 1